said on Monday a mid-stage trial of its cancer drug Enhertu showed positive results across multiple HER2-expressing advanced solid tumours in heavily pre-treated patients.
The ongoing DESTINY-PanTumor02 Phase II trial is assessing the efficacy and safety of Enhertu in patients with locally advanced or metastatic previously treated solid tumours that are not eligible for curative therapy, including cervical, ovarian, pancreatic, and rare cancers. "Enhertu has already demonstrated its potential to improve outcomes for patients with HER2-targetable breast, gastric and lung cancers, and these positive initial results in other tumour settings with significant unmet need are very encouraging," Cristian Massacesi, AstraZeneca's chief medical officer and oncology chief development officer, said in a statement.
Hard pass
Wait, AZ vax banned/withdrawn globally and we still trust these shisters?
Reuters凄
plough01
Full of MRna, cancer free but you will get a stroke per day
I'm willing to show 10 lucky people on how to earn 0.92 BTC ($15,000)and more daily. No withdrawal fee You don't get to send funds to anyone Interested please PM
Remember when they had to pull the AZ covid jab because it kills people?
16% complete response and 67% partial response on tumour shrinkage is very promising. I hope to see that day when cancer can be treated and cured just like a minor infection.
nhsrcofficial
😂😂😂 Infomercials beware
J ai perdu toute confiance en ces laboratoires faiseurs de vax!!!